ClinicalTrials.govpublic full text
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
pulmonary arterial hypertension, tyvaso, ut-15c sr, pah, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007810
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.